Biomagnetics Diagnos (BMGP)

Biomagnetics Diagnostics Corp. is a healthcare company focused on medical device and biotechnology applications. The company designs, patents, and markets diagnostic equipment, immunoassays, and related biotechnology products. Its reported technologies include the High Throughput Screening–Magnetic Testing Platform (HTS-MTP), which is intended to deliver qualitative and quantitative results from a single test by detecting target viruses through magnetic-field measurements tied to micro-particles, and the Integrated Optical Biosensor System, which uses protein-receptor binding and optical waveguides to detect fluorescence changes. Biomagnetics Diagnostics also has a licensing and collaborative research and development agreement with Los Alamos National Security LLC related to the Integrated Optical BioSensor. The company was founded in 1997 and is based in Orangevale, California. The listed security is common stock on OTC Markets under the symbol BMGP.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.